,Topics,Questions
0,A statement that the study involves research,"Which of the following statements best describes the nature of the activity described in the informed consent form?
A) A routine medical check-up with no research component
B) A clinical trial involving research to compare the efficacy of two chemotherapy drugs
C) A voluntary blood donation drive
D) An educational seminar about gastric cancer treatments

Correct answer: B) A clinical trial involving research to compare the efficacy of two chemotherapy drugs"
1,An explanation of the purposes of the research,"What is the primary purpose of the research study described in the consent form?
A) To evaluate the cost-effectiveness of D2 surgery in gastric cancer treatment; B) To compare the overall survival rate and peritoneal metastasis-free survival rate between lobaplatin and paclitaxel in advanced gastric cancer patients treated with D2 surgery and HIPEC; C) To assess the long-term side effects of hyperthermic intraperitoneal chemotherapy; D) To determine the best dietary practices for postoperative gastric cancer patients

Correct answer: B"
2,The expected duration of the subject's participation,"What is the expected duration of participation for subjects in the ""Comparative Study on the Efficacy of Lobaplatin and Paclitaxel in the Treatment of Advanced Gastric Cancer Patients""?
A) 1 year; B) 2 years; C) 3 years; D) 4 years
Correct answer: D"
3,Any additional costs to the subject that may result from participation in the research,"Which of the following statements is true regarding the additional costs for subjects participating in the research study?
A) Subjects will receive financial compensation for participating in the study.
B) Subjects will incur additional costs for the surgery and HIPEC treatment, which are based on the hospital's standard charges.
C) The cost of the study medication is covered by the research study.
D) All treatment costs associated with the study will be covered by the subject's insurance.

Correct answer: B) Subjects will incur additional costs for the surgery and HIPEC treatment, which are based on the hospital's standard charges."
4,A description of the procedures to be followed,"Which of the following best describes the timing and dosage of the HIPEC treatment with paclitaxel for patients participating in the study?

A) HIPEC with paclitaxel is administered only once postoperatively at a dosage of 50mg/m2.
B) HIPEC with paclitaxel is administered intraoperatively and then again 48 hours later at a dosage of 75mg/m2 each time.
C) HIPEC with paclitaxel is administered twice during surgery, each time at a dosage of 130mg/m2.
D) HIPEC with paclitaxel is administered once every week for four weeks at a dosage of 100mg/m2.

Correct answer: B) HIPEC with paclitaxel is administered intraoperatively and then again 48 hours later at a dosage of 75mg/m2 each time."
5,The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject,"What will happen if you choose to withdraw from the clinical trial at any point?
A) You will be required to pay a penalty for early withdrawal; B) You will be prohibited from seeking further treatment at Wuhan Union Hospital; C) Your medical treatment and rights will remain unaffected and you will not face any discrimination or retaliation; D) The researchers will continue to use your data without your consent.

Correct answer: C"
6,Identification of any procedures which are experimental,"Which of the following procedures is considered experimental in the treatment of advanced gastric cancer patients with D2 surgery in this study?
A) Standard D2 surgical resection of gastric cancer;
B) Postoperative systemic adjuvant chemotherapy with SOX/XELOX regimen;
C) Hyperthermic intraperitoneal chemotherapy (HIPEC) using either paclitaxel or lobaplatin;
D) Routine blood tests and biochemical checks before and after chemotherapy.

Correct answer: C"
7,The approximate number of subjects involved in the study,"How many patients are expected to be enrolled in the ""Comparative Study on the Efficacy of Lobaplatin and Paclitaxel in the Treatment of Advanced Gastric Cancer Patients with D2 Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy""?
A) 100 patients; B) 200 patients; C) 231 patients; D) 300 patients
Correct answer: C) 231 patients"
8,A description of any reasonably foreseeable risks or discomforts to the subject,"Which of the following is a potential risk or discomfort associated with participating in the study described in the consent form?
A) Temporary discomfort from blood draws; B) Risk of anastomotic leakage and other surgical complications; C) Increased risk of common cold; D) Guaranteed improvement in health condition

Correct answer: B"
9,A description of any benefits to the subject or to others which may reasonably be expected from the research,"Which of the following statements best describes the potential benefits of participating in the gastric cancer treatment study?
A) Participants will receive a guaranteed cure for their advanced gastric cancer.
B) Participants in the experimental group may experience a better overall therapeutic effect than the conventional regimen.
C) Participants will receive financial compensation for any kind of injury or side effect experienced during the study.
D) Participants will be exempt from all medical costs associated with the study.

Correct answer: B) Participants in the experimental group may experience a better overall therapeutic effect than the conventional regimen."
10,"A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject","What are the alternative treatment options available to the patient if they choose not to participate in the clinical trial for advanced gastric cancer patients?
A) Only palliative care with no active treatment; B) Routine surgical treatment and postoperative adjuvant chemotherapy with regimens such as SOX, XELOX, mFOLFOX6; C) Exclusive use of targeted drug therapy without surgery; D) Participation in a different clinical trial with an unrelated treatment method.
Correct answer: B"
11,"A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained","Who will have access to your identifiable health information as a participant in this study, and how will your privacy be protected?
A) Only the principal investigator and the research sponsor; B) Any member of the public upon request; C) Designated members of the research team, government management department, or ethics review committee when necessary; D) All hospital staff regardless of their involvement in the study.

Correct answer: C"
12,"For research involving more than minimal risk, an explanation as to whether any compensation, and an explanation as to whether any medical treatments are available, if injury occurs and, if so, what they consist of, or where further information may be obtained","If a participant in the study experiences an injury related to the research, what kind of compensation is available to them according to the consent form?
A) The participant will receive free medical treatment for the injury.
B) The participant will receive financial compensation in accordance with Chinese law after verification by a specialized agency.
C) The participant will receive a fixed amount of compensation regardless of the injury's severity.
D) The participant will not receive any form of compensation.

Correct answer: B) The participant will receive financial compensation in accordance with Chinese law after verification by a specialized agency."
13,"Research, Rights or Injury: An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject","If you experience any discomfort or injury during the research process, or have questions about your rights as a participant in this study, whom should you contact?

A) The Ethics Committee of Wuhan Union Hospital
B) The principal investigator of the study
C) The hospital's general information desk
D) Your personal physician

Correct answer: B) The principal investigator of the study"
14,"A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits, to which the subject is otherwise entitled","What does the consent form state about your right to withdraw from the study?
A) You may withdraw at any time, but you will lose access to certain medical treatments.
B) You may withdraw at any time, and this will not affect your access to medical treatments you are otherwise entitled to.
C) You cannot withdraw once you have signed the consent form.
D) Withdrawing from the study will result in a penalty.

Correct answer: B) You may withdraw at any time, and this will not affect your access to medical treatments you are otherwise entitled to."
